ACVRL1 and hereditary hemorrhagic telangiectasia: In contrast to mice that are heterozygous for mutations in either Eng or Acvrl1, which overall have only mild vascular defects, homozygous deletions of Eng or Acvrl1 using cell type-specific or time-dependent Cre drivers result in consistent and robust AVMs resembling those seen in HHT patients.